Self-management in type 2 diabetes patients on insulin therapy triggered by app-messages
Completed
- Conditions
- 10018424type 2 diabetes mellitusnoninsulin-dependent diabetes mellitus
- Registration Number
- NL-OMON44809
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 230
Inclusion Criteria
Type 2 diabetes patients who are on insulin treatment since at least 3 months, with a baseline HbA1c level >7% (53 mmol/mol) aged 40-70 years. Logistic requirements are the possession of an e-mail address and a smartphone.
Exclusion Criteria
Insulin naïve type 2 diabetes patients, patients with a history of alcoholism, drug abuse, dementia or major psychiatric disorder that is likely to invalidate informed consent, or limit the ability of the individual to comply with the protocol requirements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary study endpoints are 1) the percentage of patients who achieve an<br /><br>HbA1c level *7% (53 mmol/mol) without hypoglycaemia (plasma glucose <3.5 mmol/L<br /><br>(63 mg/dL) and 2) the HbA1c level as a continuous outcome variable after a<br /><br>follow-up duration of 6 months.</p><br>
- Secondary Outcome Measures
Name Time Method